Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma, Co KgfiledCriticalBoehringer Ingelheim Pharma
Priority to UY27196ApriorityCriticalpatent/UY27196A1/en
Publication of UY27196A1publicationCriticalpatent/UY27196A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
El presente invento se refiere a nuevas composiciones de medicamentos sobre la base de agentes anticolinérgicos e inhibidores de PDE-IV, a procedimientos para su preparación así como a su utilización en la terapia de enfermedades de las vías respiratorias.The present invention relates to new compositions of medicaments based on anticholinergic agents and PDE-IV inhibitors, methods for their preparation as well as their use in the therapy of respiratory tract diseases.
UY27196A2002-03-062002-03-06
NEW COMPOSITIONS OF MEDICINES ON THE BASE OF ANTI-POLYNERGIC AGENTS AND INHIBITORS OF PDE-IV
UY27196A1
(en)
PHARMACEUTICAL COMPOSITION, PRODUCT AND TREATMENT METHOD FOR A COGNITIVE DISORDER AND USES OF AN ACETILCOLINESTERASE INHIBITOR AND A 5- HT6 ANTAGONIST IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A COGNITIVE DISORDER
PHARMACEUTICAL COMPOSITION OF 4-{[9-CHLORO-7-(2-FLUORO-6-METHOXYPHENYL)-5H-PYRIMIDO[5,4-d][2]BENZAZIPINE-2-YL]AMINO}-2-METHOXT BENZOIC ACID FOR TREATMENT OF CANCER AND OTHER DISEASES AND IMPAIRED HEALTH CONDITIONS